Community

Michael Luther

President and CEO, Teewinot Life Sciences Corporation

Dr. Luther has 30+ years of experience leading biopharmaceutical companies and opera¬tions. His leadership roles range from early drug development to corporate development in start-ups to global pharmaceutical companies, including Merck and GSK. Dr. Luther came to TLS from Bantam Pharmaceuticals where he was the CEO. He was also at AMRI where he was the SVP of discovery and development. Dr. Luther holds a B.S. from North Carolina State, an MBA from the Duke University Fuqua School of Business and a Ph.D. from the St. Louis University School of Medicine.

Community

Michael Luther

President and CEO, Teewinot Life Sciences Corporation

Contributions

Leveraging Biosynthetic Expertise to Access a Wide Portfolio of Cannabinoids